NTLA
Intellia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.74
+0.47%Leverage
- Debt / equity
- 0.10x
- Net debt / equity
- -0.04x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- 0.08x
Liquidity & coverage
- Current ratio
- 6.65x
- Quick ratio
- 6.65x
- Cash ratio
- 5.51x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $448.4M
Cash & dividend
- FCF / debt
- -6.35x
- Cash flow / debt
- -6.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026